Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity.

By A. Barsky, E. J. Orav, David W. Bates. Archives of General Psychiatry, 2005

886 citations recorded by the source corpus.

CONTEXT Somatoform disorders are an important determinant of medical care utilization, but their independent effect on utilization is difficult to determine because somatizing patients frequently have psychiatric and medical comorbidity. OBJECTIVES To assess the extent of the overlap of somatization with other psychiatric disorders; to compare the medical utilization of somatizing and nonsomatizing patients; and to determine the independent contribution of somatization alone to utilization. DESIGN Patients were surveyed with self-report questionnaires assessing somatization and psychiatric disorder. Medical care utilization was obtained from automated encounter data for the year preceding the index visit. Medical morbidity was indexed with a computerized medical record audit. SETTING Two hospital-affiliated primary care practices. PARTICIPANTS Consecutive adults making scheduled visits to their primary care physicians on randomly chosen days. In all, 2668 questionnaires were distributed, and 1914 (71.7%) were returned. Of these, 1546 (80.8%) contained complete data and met eligibility criteria. MAIN OUTCOME MEASURES Medical care utilization and costs within our hospital system in the preceding 12 months. RESULTS Two hundred ninety-nine patients (20.5%) received a provisional diagnosis of somatization; 42.3% of these patients had no comorbid depressive or anxiety disorder. Somatizing patients, when compared with nonsomatizing patients, had more primary care visits (mean [SE], 4.90 [0.32] vs 3.43 [0.11]; P<.001); more specialty visits (mean [SE], 8.13 [0.55] vs 4.90 [0.21]; P<.001); more emergency department visits (mean [SE], 1.29 [0.15] vs 0.52 [0.036]; P<.001); more hospital admissions (mean [SE], 0.32 [0.051] vs 0.13 [0.014]; P<.001); higher inpatient costs (mean [SE], USD 3146 [USD 380] vs USD 991 [USD 193]; P<.001); and higher outpatient costs (mean [SE], USD 3208 [USD 180] vs USD 1771 [USD 91]; P<.001). When these results were adjusted for the presence of comorbid anxiety and depressive disorders, major medical morbidity, and sociodemographic characteristics, patients with somatoform disorder still had more primary care visits (P = .04), more specialist visits (P = .002), more emergency department visits (P<.001), more hospital admissions (P<.001), more ambulatory procedures (P<.001), higher inpatient costs (P<.001), and higher outpatient costs (P<.001). When these findings are extrapolated to the national level, an estimated USD 256 billion a year in medical care costs are attributable to the incremental effect of somatization alone. CONCLUSIONS Patients with somatization had approximately twice the outpatient and inpatient medical care utilization and twice the annual medical care costs of nonsomatizing patients. Adjusting the findings for the presence of psychiatric and medical comorbidity had relatively little effect on this association.

Subfields: Clinical Psychology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/aae834cba67e2d116486fcc6dacf4932e95d55d4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Psychology

In Psychiatry and Mental health

Citations in the corpus

Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. (2008, background): “Fourth, it is an excellent measure for identifying high-utilizing somatizing patients in health care systems [5,41].”
The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. (2010, background): “Fourth, it is an excellent measure for identifying highutilizing somatizing patients in health care systems [145,146].”
Managerial support for basic psychological needs, somatic symptom burden and work-related correlates: A self-determination theory perspective (2014, background): “Indeed, the consequences of somatic symptom burden extend beyond the individual and affect society at large, as manifested in higher levels of medical utilization and lower levels of job productivity (Barsky et al., 2005).”
Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection (2007, background): “In addition, these treatments may also be beneficial in some somatoform disorders and somatic syndromes that accompany anxiety and depressive disorders (59–61) and result in substantial health care costs (62).”